Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in immunotoxins.

T N Oeltmann1, A E Frankel

  • 1Department of Medicine, Vanderbilt Medical School, Nashville, Tennessee 37232.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma.

Current drug targets·2009
Same author

Autophagy regulates selective HMGB1 release in tumor cells that are destined to die.

Cell death and differentiation·2008
Same author

Acute-myeloid-leukemia-targeted toxins kill tumor cells by cell-type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell death.

Leukemia·2007
Same author

Induction of apoptosis by tumor cell-targeted toxins.

Apoptosis : an international journal on programmed cell death·2004
Same author

Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice.

Leukemia·2003
Same author

Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia.

Leukemia & lymphoma·2002
Same journal

Sinomenine Regulates the TRIM32/IRF1/TRAF6 Axis to Inhibit Pyroptosis in Atopic Dermatitis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Urolithin A Mitigates Renal Fibrosis by Promoting Fatty Acid Oxidation Through Orchestrating β-Catenin Signaling.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

MiR-124 Inhibits Lipid Deposition in Mouse Liver by Targeting the Trib3/Hnf4α Pathway.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

TCN2 Drives Psoriasis-Like Inflammation and Keratinocyte Hyperproliferation, Correlating With IL-1β and STAT3 Activation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

The Synthetic Melanocortin Agonist NDP-MSH Ameliorates THSD7A-Associated Membranous Nephropathy in an Active Immunization Mouse Model.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Brain-Derived Neurotrophic Factor and Associated Signaling in Kidney Diseases.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
See all related articles

Immunotoxin research is expanding, with significant advances in molecular biology and clinical applications. Future work will focus on peptide toxin mechanisms and targeted toxin design for treating human diseases.

Area of Science:

  • Immunotoxin research and development.

Background:

  • The field of immunotoxins is experiencing significant growth, evidenced by increased attendance and abstract submissions at recent symposia.
  • Key advancements in the molecular biology of toxins and their clinical applications were highlighted.

Framework:

  • Focus on defining the mechanism of action for peptide toxins.
  • Improvements in the design of targeted toxins for therapeutic purposes.

Implementation:

  • Continued research into molecular biology of toxins.
  • Development of targeted toxin therapies.

Implications:

  • Potential for novel therapies targeting a wide range of human diseases.
  • Enhanced understanding of peptide toxin mechanisms.

Related Experiment Videos

  • Improved design of targeted immunotoxins for clinical use.